SCHEMBL21147392

SCHEMBL21147392

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5cccc(-c6cccc7oc8ccccc8c67)c5)cc4)nc(-c4cccc(-c5cccc6oc7ccccc7c56)c4)n3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.43
PLA2G4A P47712 3/20 0.43
PLA2G10 O15496 1/20 0.41
ALOX5 P09917 1/20 0.40
MAPT P10636 4/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ATM Q13315 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PIM1 P11309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21147372 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL19196589 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL25645672 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL21147385 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL21148583 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL25645667 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL21148519 0.99 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL23822703 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL21148168 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALOX5MAPT
SCHEMBL21109245 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALOX5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CRY1, CYP1B1, CYP1A1 PLA2G2A 4266/4885PLA2G4A 4371/4885PLA2G10 4214/4885
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND CRY1, CYP1B1, CYP1A1 PLA2G2A 4266/4885PLA2G4A 4371/4885PLA2G10 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.